J. Lipid Res. Please sign the JLR Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on October 1, 2007

Papers In Press, published online ahead of print July 13, 2007
J. Lipid Res., doi:10.1194/jlr.M700098-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M700098-JLR200v1
48/10/2162    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stewart, C. R.
Right arrow Articles by O'Brien, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stewart, C. R.
Right arrow Articles by O'Brien, K. D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on February 23, 2007
Revised on July 3, 2007
Accepted on July 12, 2007

Serum amyloid P co-localizes with apolipoproteins in human atheroma: Functional implications

Cameron R. Stewart, Antonio Haw, Roland Lopez, Thomas O. McDonald, Judy M. Callaghan, Malcolm J. McConville, Kathryn J. Moore, Geoffrey J. Howlett, and Kevin D. O'Brien

Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Victoria 3010

Corresponding Author: ghowlett{at}unimelb.edu.au

Serum amyloid P (SAP) is a common component of human amyloid deposits, and has been identified in atherosclerotic lesions. We investigated the extent of the co-localization of SAP with apolipoproteins A-I, B, C-II and E in human coronary arteries, and explored potential roles for SAP in these regions; specifically, the effect of SAP on the rate of formation and macrophage recognition of amyloid fibrils composed of apolipoprotein (apo) C-II. Analysis of 42 human arterial sections by immunohistochemistry and double label fluorescence microscopy demonstrated that SAP and apoA-I, B, C-II and E were significantly elevated in atherosclerotic lesions compared to non-atherosclerotic segments. SAP co-localized with all four apolipoproteins to a similar extent, whereas plaque macrophages were found to correlate most strongly with apoC-II and apoB. In vitro studies showed that SAP accelerated the formation of amyloid fibrils by purified apoC-II. Furthermore, SAP strongly inhibited phagocytosis of apoC-II amyloid fibrils by primary macrophages and macrophage cell lines, and blocked the resultant production of reactive oxygen species. The ability of SAP to accelerate apoC-II amyloid fibril formation and inhibit macrophage recognition of apoC-II fibrils suggests that SAP may modulate the inflammatory response to amyloid fibrils in atherosclerosis.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
M. J. Gunzburg, M. A. Perugini, and G. J. Howlett
Structural Basis for the Recognition and Cross-linking of Amyloid Fibrils by Human Apolipoprotein E
J. Biol. Chem., December 7, 2007; 282(49): 35831 - 35841.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.